Screener
Royalty Pharma RPRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's current ratio?
- Royalty Pharma (RPRX) reported current ratio of 2.8× in Q2 2026.
- How has Royalty Pharma's current ratio changed year-over-year?
- Royalty Pharma's current ratio increased by 122.0% year-over-year, from 1.3× to 2.8×.
- What is the long-term trend for Royalty Pharma's current ratio?
- Over 5 years (2020 to 2025), Royalty Pharma's current ratio has grown at a -22.8% compound annual growth rate (CAGR), from 8.8× to 2.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Royalty Pharma's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude